18/10/23	Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	CI
10/10/23	FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	CI
03/10/23	Motion for Asset Sale Approved for MusclePharm Corporation	CI
27/09/23	FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.	CI
08/09/23	Stalking Horse Agreement Filed by MusclePharm Corporation	CI
01/09/23	Musclepharm Corporation Announces Resignation of Paul Karr as Director	CI
28/08/23	Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	CI
28/08/23	First Amended Disclosure Statement Approved for MusclePharm Corporation	CI
17/08/23	Bidding Procedure Approved for MusclePharm Corporation	CI
19/07/23	Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer	CI
19/06/23	First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation	CI
26/05/23	Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	CI
12/05/23	Motion for Asset Sale Filed by MusclePharm Corporation	CI

28/06/23	SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud	AQ
29/09/22	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ
19/09/22	MusclePharm : Accelaration/Increase of Financial Obligation - Form 8-K	PU
19/09/22	MUSCLEPHARM CORP : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement (form 8-K)	AQ
23/08/22	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ

1 day

+12.00%

Manager	Title	Age	Since
Tyler Jeffrey Dillashaw PRN	Corporate Officer/Principal	-	01/10/2021
Jason Keenan PRN	Corporate Officer/Principal	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MUSCLEPHARM CORPORATION	+12.00%	+86.67%	-	-	33
EINRIDE AB	+2.10%	-14.92%	-	-	1.18B
CENTIEL AG	+2.19%	+10.18%	+427.50%	-57.59%	831M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	-0.10%	+0.10%	-	-	643M
BAIN CAPITAL GSS INVESTMENT CORP.	+0.59%	+0.59%	-	-	596M
CANTOR EQUITY PARTNERS IV, INC.	-0.24%	+0.10%	-	-	593M
CHURCHILL CAPITAL CORP XI	+0.24%	+0.88%	-	-	574M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	+0.54%	-0.93%	-	-	551M
ENHANCED GROUP INC.	+0.23%	+13.88%	-	-	541M
Average	+1.89%	+0.66%	+427.50%	-57.59%	688.61M
Weighted average by Cap.	+0.82%	-1.14%	+427.50%	-57.59%